Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajagopal Bakthavatchalam

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Topics in Medicinal Chemistry|June 16, 2011
Transient receptor potential A1 modulatorsTim Strassmaier, Rajagopal Bakthavatchalam
Expert Opinion on Therapeutic Patents|June 12, 2014
Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 - 2013)Raghava R Kethiri, Rajagopal Bakthavatchalam
Bioorganic & Medicinal Chemistry Letters|July 10, 2010
Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolitesKevin J Hodgetts, Charles A Blum, Timothy Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonistXiaozhang Zheng, Kevin J Hodgetts, Harry Brielmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptorsGe Zhang, Ning Huang, Yu-Wen Li, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
Aminoquinazolines as TRPV1 antagonists: modulation of drug-like properties through the exploration of 2-position substitutionCharles A Blum, Xiaozhang Zheng, Harry Brielmann, et al.
Journal of Medicinal Chemistry|March 24, 2010
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonistsCharles A Blum, Timothy Caldwell, Xiaozhang Zheng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|June 16, 2011
Transient receptor potential A1 modulatorsTim Strassmaier, Rajagopal Bakthavatchalam
Expert Opinion on Therapeutic Patents|June 12, 2014
Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 - 2013)Raghava R Kethiri, Rajagopal Bakthavatchalam
Bioorganic & Medicinal Chemistry Letters|July 10, 2010
Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolitesKevin J Hodgetts, Charles A Blum, Timothy Caldwell, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonistXiaozhang Zheng, Kevin J Hodgetts, Harry Brielmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Pharmacological characterization of a novel nonpeptide antagonist radioligand, (+/-)-N-[2-methyl-4-methoxyphenyl]-1-(1-(methoxymethyl) propyl)-6-methyl-1H-1,2,3-triazolo[4,5-c]pyridin-4-amine ([3H]SN003) for corticotropin-releasing factor1 receptorsGe Zhang, Ning Huang, Yu-Wen Li, et al.
Bioorganic & Medicinal Chemistry Letters|July 30, 2008
Aminoquinazolines as TRPV1 antagonists: modulation of drug-like properties through the exploration of 2-position substitutionCharles A Blum, Xiaozhang Zheng, Harry Brielmann, et al.
Journal of Medicinal Chemistry|March 24, 2010
Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonistsCharles A Blum, Timothy Caldwell, Xiaozhang Zheng, et al.
Pageof 1